An erectile dysfunction evaluation is more than a conversation about sexual performance. Because erections depend on coordinated vascular, neurologic, hormonal, and psychological systems, a persistent change can reveal an untreated health condition. Most men do not need an extensive panel of specialized tests. A careful history, focused examination, and a few targeted laboratory measurements usually provide the clinically useful starting point.
Why Erectile Dysfunction Deserves a Medical Evaluation
Erectile dysfunction is the persistent difficulty achieving or maintaining an erection sufficient for satisfactory sexual activity. A single difficult night is not the same as a persistent pattern. Temporary changes may follow stress, fatigue, heavy alcohol use, acute illness, or relationship conflict. Evaluation becomes more important when the problem recurs, progresses, or causes distress.
The reason to look beyond the symptom is physiological. Penile arteries are small and depend on healthy endothelium—the cellular lining that regulates vascular relaxation. Diabetes, high blood pressure, abnormal cholesterol, smoking, and atherosclerosis can impair this system before cardiovascular disease becomes otherwise obvious. An umbrella review found that men with erectile dysfunction had a 45% higher relative risk of cardiovascular disease and a 55% higher relative risk of myocardial infarction than men without erectile dysfunction.[1] Association does not prove that erectile dysfunction causes these events, but it supports using the symptom as an opportunity for risk assessment.
The 2024 Princeton IV Consensus recommends treating men with predominantly vascular erectile dysfunction as potentially at increased cardiac risk until evaluated. It also emphasizes cardiovascular risk stratification and, for selected men with borderline or intermediate estimated risk, consideration of coronary artery calcium scoring.[2] This does not mean that every man with erection difficulty needs a heart scan. It means the clinician should not prescribe in isolation from blood pressure, metabolic health, exercise tolerance, symptoms, and medication history.
Prompt evaluation is especially important when erectile dysfunction begins suddenly after pelvic trauma, occurs with penile pain or curvature, follows surgery, or accompanies chest pain, shortness of breath, fainting, or major loss of exercise capacity. An erection lasting longer than four hours requires emergency care.
The History: Often the Most Informative Test
A useful assessment starts with timing and pattern. The clinician may ask whether the change was sudden or gradual, whether erections occur during sleep or masturbation, whether rigidity is difficult to achieve or to maintain, and whether sexual desire, orgasm, or ejaculation has changed. Preserved spontaneous erections do not prove a purely psychological cause, but they can help frame the differential diagnosis.
Validated questionnaires make the description more consistent. The International Index of Erectile Function and its shorter version, the Sexual Health Inventory for Men, quantify erection confidence, firmness, maintenance, and satisfaction. They help establish severity and provide a baseline for measuring treatment response. They are screening and monitoring tools, not stand-alone diagnoses.
Medical history may expose reversible contributors. Antidepressants, some blood-pressure drugs, opioids, antiandrogens, and other medicines can affect sexual function. Medication should never be stopped abruptly without the prescribing clinician. The review also covers diabetes, cardiovascular disease, sleep apnea, depression, anxiety, prostate treatment, neurologic disease, pelvic injury, alcohol, nicotine, recreational drugs, and exercise habits.
Relationship context and performance anxiety matter without making the symptom “imaginary.” Anxiety activates sympathetic nervous-system pathways that oppose the relaxed vascular state required for erection. Psychological and biological contributors often coexist; a gradual vascular limitation can generate anticipatory anxiety, which then makes the physical problem more pronounced.
Erectile Dysfunction Evaluation: Examination and Blood Tests
The physical examination is focused rather than invasive. Blood pressure, heart rate, body mass index, or waist circumference can identify cardiometabolic risk. The clinician may assess pulses and signs of vascular disease, examine the penis for plaques or curvature, evaluate the testes, and look for features that could suggest low testosterone or neurologic dysfunction.
Current European Association of Urology guidance recommends fasting glucose or hemoglobin A1c and a lipid profile when these have not been assessed within the preceding year. These tests look for diabetes and dyslipidemia, two common contributors to endothelial dysfunction. Results can change long-term health management even when they do not identify a single cause for the erection problem.[3]
An early-morning total testosterone measurement is commonly included. Testosterone varies during the day, and a low value generally needs confirmation on a separate morning before hypogonadism is diagnosed. Symptoms such as reduced desire, loss of body hair, low energy, reduced muscle mass, infertility, or small testes can increase clinical suspicion. Depending on the result and symptoms, a clinician may order free testosterone, luteinizing hormone, prolactin, or thyroid studies.
Broad laboratory panels are not automatically helpful. Kidney function, blood count, thyroid markers, or other tests are selected from the history and examination. More testing can produce incidental abnormalities without clarifying the cause. The goal is a targeted work-up that identifies modifiable risk, not a search for a perfect biomarker of erection quality.
Cardiovascular assessment is also individualized. The Princeton IV recommendations incorporate standard 10-year atherosclerotic cardiovascular disease risk estimates for men with likely vasculogenic erectile dysfunction. Men with unstable chest symptoms, uncontrolled blood pressure, advanced heart failure, or high-risk rhythm problems may need cardiac stabilization before sexual activity or ED treatment.[2]
When Specialized Testing Is Appropriate
Most men can begin management without imaging. Specialized testing is generally reserved for diagnostic uncertainty, pelvic trauma, suspected vascular abnormalities, complex endocrine disease, consideration of surgery, or an inadequate response to appropriately used first-line treatment.
Penile duplex Doppler ultrasound measures arterial inflow and venous outflow after medication is used to stimulate an erection. It can help distinguish reduced arterial supply from failure to retain blood. Interpretation depends on technique, medication response, anxiety, and operator experience. It is not a routine screening test. A review of cardiovascular evidence noted that reduced penile arterial flow measurements can also correlate with later major cardiovascular events, reinforcing the shared vascular biology.[4]
Nocturnal penile tumescence and rigidity monitoring records erections during sleep, usually across at least two nights. Preserved sleep-related erections may suggest intact erectile structures, but sleep quality, depression, medication, and device limitations can affect results. The test is now used selectively rather than as a universal way to separate physical from psychological causes.
Intracavernosal injection testing evaluates the erectile response to a medication placed directly into the penis. It may be combined with ultrasound. Cavernosography and arterial imaging are much less common and are generally reserved for men being assessed for reconstructive procedures. Neurologic testing is similarly guided by symptoms rather than routinely performed.
Psychosexual evaluation is a specialized test in a broader sense. It can identify performance anxiety, depression, trauma, relationship conflict, or maladaptive beliefs that sustain symptoms. Referral does not exclude physical disease; it recognizes that sexual function is a coordinated brain-body process.
Turning Results Into a Treatment Plan
Evaluation should lead to a plan proportional to the findings. Cardiometabolic contributors may call for blood-pressure management, diabetes care, lipid treatment, smoking cessation, improved sleep, and regular aerobic activity. These measures may support erectile function while reducing broader health risk, although improvement is not guaranteed or immediate.
When low testosterone is repeatedly confirmed alongside compatible symptoms, clinicians investigate the cause and discuss the benefits, limits, fertility effects, and monitoring requirements of treatment. Testosterone is not an all-purpose erection drug, and normal testosterone levels do not justify supplementation.
Prescription phosphodiesterase type 5 inhibitors are established first-line options for many men. They enhance nitric-oxide signaling during sexual stimulation but do not create automatic arousal. Dose, timing, food effects, and adequate stimulation influence response. Nitrates for chest pain must not be combined with PDE5 inhibitors because the interaction can cause a dangerous fall in blood pressure. Other cardiovascular medications and health conditions should also be reviewed by the prescriber.
If initial treatment does not work, the next step is not necessarily an immediate switch to invasive therapy. Clinicians first confirm correct use, adequate attempts, tolerability, and whether the original diagnosis needs refinement. Depending on the findings, options may include counseling, vacuum devices, injection therapy, specialist referral, or surgery.
Conclusion
An erectile dysfunction evaluation is designed to identify patterns, contributors, and health risks—not to subject every man to extensive testing. History, validated questionnaires, focused examination, glucose or A1c, lipids, and morning testosterone answer most first-line questions. Vascular imaging, nocturnal monitoring, and other specialized studies have narrower roles. The central clinical message is that persistent erectile dysfunction deserves attention because it may reflect treatable sexual, metabolic, hormonal, psychological, or cardiovascular factors.
If you're exploring clinically-formulated options, OnyxMD offers physician-supervised treatment plans starting with a free online assessment at questionnaire.getonyxmd.com. More evidence-first men's health articles are available in the blog.
These statements have not been evaluated by the FDA. This content is for informational purposes only and does not constitute medical advice.
References
Mostafaei H, Mori K, Hajebrahimi S, Abufaraj M, Karakiewicz PI, Shariat SF. Association of erectile dysfunction and cardiovascular disease: an umbrella review of systematic reviews and meta-analyses. BJU International. 2021;128(1):3-11. doi:10.1111/bju.15313
Kloner RA, Burnett AL, Miner M, et al. The Princeton IV Consensus Recommendations for the Management of Erectile Dysfunction and Cardiovascular Disease. Mayo Clinic Proceedings. 2024;99(9):1500-1517. doi:10.1016/j.mayocp.2024.06.002
Salonia A, Bettocchi C, Capogrosso P, et al. European Association of Urology Guidelines on Sexual and Reproductive Health: Management of Erectile Dysfunction. European Association of Urology. 2024. Guideline
Yannas D, Frizza F, Vignozzi L, Corona G, Maggi M, Rastrelli G. Erectile dysfunction is a hallmark of cardiovascular disease: unavoidable matter of fact or opportunity to improve men's health? Journal of Clinical Medicine. 2021;10(10):2221. doi:10.3390/jcm10102221
Zhao B, Hong Z, Wei Y, Yu D, Xu J, Zhang W. Erectile dysfunction predicts cardiovascular events as an independent risk factor: a systematic review and meta-analysis. The Journal of Sexual Medicine. 2019;16(7):1005-1017. doi:10.1016/j.jsxm.2019.04.004
Medical Disclaimer: The information provided on this website is for educational and informational purposes only and is not intended as medical advice. OnyxMD services should not be used to diagnose, treat, cure, or prevent any disease or medical condition. Always consult with a qualified healthcare provider before beginning any supplement regimen or health program.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Individual Results: Results may vary. The experiences and testimonials presented on this website are individual results that may not be typical. Your experience may be different.
Telehealth Services: OnyxMD provides telehealth services in 47 states (excluding AK, MS, NJ) through licensed healthcare providers via our partner Beluga Health, P.A. Services are subject to clinical evaluation and may not be appropriate for all individuals. Prescriptions fulfilled by Strive Pharmacy LLC (License #99-9817) and EPIQ SCRIPTS LLC.